Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Female Population
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2017
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 25 Feb 2016 Results assessing adherence and acceptability across study group and in random subset of 24 subjects presented at the 23rd Conference on Retroviruses and Opportunistic Infections.
- 25 Feb 2016 Results assesing safety and pharmacokinetics presented at the 23rd Conference on Retroviruses and Opportunistic Infections.
- 09 Sep 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.